investment trends in regenerative medicine

Investment trends in regenerative medicine are entering a more disciplined phase as U.S. capital markets recalibrate expectations around clinical timelines, manufacturing scalability, and regulatory clarity. While early enthusiasm was fueled by breakthrough science in cell and gene therapy, investors are now prioritizing platforms that demonstrate reproducible manufacturing, defined regulatory pathways, and credible reimbursement strategies. Regenerative … Read more